Cannabinoid hyperemesis syndrome as the underlying cause of intractable nausea and vomiting

Journal of the American Osteopathic Association

Volumn 111, Issue 3, 2011, Pages 166-169

  Price, Stephanie L ^a,b   Fisher, Cynthia ^a   Kumar, Ravinder ^a   Hilgerson, Alan ^a  

^a BROADLAWNS MEDICAL CENTER   (United States)

^b Des Moines University College of Osteopathic Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; HUMAN; MALE; NAUSEA; SYNDROME; VOMITING;

ADULT; CANNABIS; HUMANS; MALE; NAUSEA; SYNDROME; VOMITING;

EID: 79954457964     PISSN: 00986151     EISSN: 00986151     Source Type: Journal    
DOI: 10.7556/jaoa.2011.111.3.166     Document Type: Article

References (14)

1. Wallace D, Martin AL, Park B. Cannabinoid hyperemesis: marijuana puts patients in hot water. Australas Psychiatry. 2007;15(2):156-158.
2. Soriano-Co M, Batke M, Cappell MS. The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States [published online ahead of print February 4, 2010]. Dig Dis Sci. 2010;55(11):3113-3119.
3. Donnino MW, Cocchi MN, Miller J, Fisher J. Cannabinoid hyperemesis: a case series [published online ahead of print September 16, 2009]. J Emerg Med. doi:10.1016/j.jemermed.2009.07.033.
4. Sontineni SP, Chaudhary S, Sontineni V, Lanspa SJ. Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse. World J Gatroenterol. 2009;15(10):1264-1266.
5. Pagotto U, Marsicano G, Fezza F, et al. Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level. J Clin Endocrinol Metab. 2001;86(6):2687-2696.
6. Compton WM, Grant BF, Colliver JD, Glantz MD, Stinson FS. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA. 2004;291(17): 2114-2121.
7. National Institute on Drug Abuse. NIDA info facts: marijuana. National Institutes of Health Web site. http://www.drugabuse.gov/infofacts/marijuana.html. Accessed February 4, 2011.
8. Allen JH, de Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004;53(11):1566-1570.
9. Chang YH, Windish DM. Cannabinoid hyperemesis relieved by compulsive bathing. Mayo Clin Proc. 2009;84(1):76-78.
10. Pertwee RG. Cannabinoids and the gastrointestinal tract. Gut. 2001;48(6): 859-867.
11. Albibi R, McCallum RW. Metoclopromide: pharmacology and clinical application. Ann Intern Med. 1983;98(1):86-95.
12. Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258(5090):1946-1949.
13. Walsh D, Nelson KA, Mahmoud FA. Established and potential therapeutic applications of cannabinoids in oncology. Support Care Cancer. 2003;11(3):137-143.
14. Howlett AC, Barth F, Bonnie TI, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 2002;54(2):161-202.